• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 AVAULTA SOLO SYNTHETIC SUPPORT SYSTEM - ANTERIOR; AVAULTA SOLO® SYNTHETIC SUPPORT SYSTEM - ANTERIOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 AVAULTA SOLO SYNTHETIC SUPPORT SYSTEM - ANTERIOR; AVAULTA SOLO® SYNTHETIC SUPPORT SYSTEM - ANTERIOR Back to Search Results
Catalog Number 486100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Bacterial Infection (1735); Erosion (1750); Diarrhea (1811); Flatus (1865); Foreign Body Reaction (1868); Gastritis (1874); Hemorrhage/Bleeding (1888); Incontinence (1928); Unspecified Infection (1930); Inflammation (1932); Necrosis (1971); Pain (1994); Scar Tissue (2060); Urinary Retention (2119); Urinary Tract Infection (2120); Abnormal Vaginal Discharge (2123); Burning Sensation (2146); Chills (2191); Dysphasia (2195); Hernia (2240); Stenosis (2263); Urinary Frequency (2275); Discomfort (2330); Depression (2361); Prolapse (2475); Sleep Dysfunction (2517); Dysuria (2684); Foreign Body In Patient (2687); Constipation (3274); Dyspareunia (4505); Cramp(s) /Muscle Spasm(s) (4521); Swelling/ Edema (4577)
Event Type  Injury  
Manufacturer Narrative
The sample was not returned.The finished product met all specifications prior to being released for general distribution.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the adverse events: ¿complications associated with the proper implantation of the avaulta solo¿ synthetic support may include, but are not limited to those typically associated with surgically implantable materials, including: postoperative hematoma, seroma, abscess or fistula formation, or scarring which may occur following the implant procedure.Urinary retention, bladder outlet obstruction and other voiding and defecatory dysfunctions.These conditions may be associated with over-correction/too much tension placed on the implant.Perforations or lacerations of vessels, nerves, bladder, bowel, urethra, rectum, or any viscera, which may occur during the implantation procedure.Irritation at the operative wound site which may elicit a foreign body response that leads to wound dehiscence, inflammation and/or infection.Extrusion through vaginal epithelium or erosion into surrounding viscera and/or mucosa.Inflammation, sensitization, pain, dyspareunia, scarification, contraction, device migration and failure of the procedure resulting in recurrence of vaginal wall prolapse.Urinary incontinence (stress and urge)." 1750, 1869 = "l" 2348, 2361, 2597, 2993 = "nl".
 
Event Description
The patient¿s attorney alleged a deficiency against the device.Additional information has been requested, but not yet received.Product was used for therapeutic treatment.Per additional information received, the patient has experienced depression, blood loss, pain in legs, right groin swelling, vaginal discharge, sensation of mesh coming out, vaginal pressure, tenderness, pain with sexual intercourse, palpable mesh, discomfort, urine leakage, sensation of a ¿bubble¿ in vagina, vaginal pain, bacilluria (bacterial infection), cystocele, dryness, urinary tract infection (uti), dysuria, mixed/urge/stress incontinence, palpable band of fibrous tissue (fibrosis), scar tissue, urinary frequency, burning sensation during intercourse, nocturia, back pain, night sweats, eroded mesh, mesh embedded in bladder (foreign body in patient), chronic inflammation, foreign material, foreign body giant cell reaction (foreign body reaction), vaginitis/vulvovaginitis, femoral hernia (hernia), and required additional surgical and non-surgical interventions.Per additional information received, the patient has experienced erosion of transvaginal mesh, pain, infection, unspecified urinary problems, recurrence, dyspareunia (pain) and required additional surgical interventions.Per additional information received via medical records on (b)(6) 2018, the patient has experienced pain, tenderness, dyspareunia, erosion, discharge, infection, dropped bladder, foreign body in patient, mixed incontinence, foreign body sensation, pelvic pain, inflammation, nerve damage, pain with sitting, nocturia, sleep disturbance, pressure while urinating, irritable bowel syndrome, chronic diarrhea, pelvic trauma, throbbing/stabbing vaginal pain, vaginal discharge, urinary retention, uterine prolapse, unspecified urinary problems, recurrence, cramping, muscle spasms, depression, elevated blood pressure, blood loss, chills, vaginal pain, burning sensation, night sweats, dysuria, leukocytes in urine, bladder neck hypermobility, foreign body reaction, vaginitis/vulvovaginitis, hernia, swelling, cystocele (prolapse), vaginal dryness, induration, pressure, discomfort, leakage, scar tissue, urinary tract infection, bacilluria, groin pain, nonsurgical and additional surgical interventions.Per additional information received via medical records on (b)(6) 2021, the patient has experienced mesh erosion, vaginal pain, burning on intercourse, dysuria, and yellowish discharge, painful urination, urinary frequency, dryness, extensive fibrosis, inflammation, focal fibrinoid necrosis, tenderness, dyspareunia, infection, reemerging incontinence, chronic pelvic pain, thoracic pain, vaginal stenosis, mixed urge and stress incontinence, vaginal discharge, knee pain, hip pain, right and left characterized as sharp pain, shooting pain, aching aggravated by walking, standing, joint pain.Back pain, achy in nature, constant, sharp, throbbing, located in the cervical, thoracic, and lumbar region on the right, left and midline, aggravated by activity, bending, lifting.Leg pain achy in nature, constant, sharp, shooting, located in the left and right upper and lower leg, aggravated by activity, mild vaginal atrophy, unspecified vaginitis and vulvovaginitis, epigastric pain, esophageal reflux, atrophic gastritis, diaphragmatic hernia, diarrhea, coronary artery disease, dysphagia, flatulence, mild antral gastritis, mild bile reflux, facet joint syndrome and required additional surgical and non-surgical interventions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVAULTA SOLO SYNTHETIC SUPPORT SYSTEM - ANTERIOR
Type of Device
AVAULTA SOLO® SYNTHETIC SUPPORT SYSTEM - ANTERIOR
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
yonic anderson
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key11806363
MDR Text Key249998763
Report Number1018233-2021-80039
Device Sequence Number1
Product Code OTP
UDI-Device Identifier00801741168024
UDI-Public(01)00801741168024
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K082571
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 05/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2011
Device Catalogue Number486100
Device Lot NumberHUTF2232
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Device Age19 MO
Event Location Hospital
Date Manufacturer Received05/04/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/25/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CAPIO¿ SLIMSUTURE CAPTURING DEVICE; PELVILACE® TO BIOURETHRAL SUPPORT SYSTEM HOOK
Patient Outcome(s) Required Intervention;
Patient Age47 YR
Patient Weight86
-
-